Publikationen in Zusammenarbeit mit Forschern von UCLA Medical Center (1)

2018

  1. Phase III randomized study of ribociclib and fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: MONALEESA-3

    Journal of Clinical Oncology, Vol. 36, Núm. 24, pp. 2465-2472